Mandate

Vinge advises Orkla on its divestment of Enter Fonder to Pareto

April 04, 2016

Vinge advises Orkla ASA on the divestment (indirectly) of its shares in Enter Fonder to Pareto AS. The transaction makes Pareto the new majority shareholder of Enter. The transaction is subject to relevant approvals from the Swedish Financial Supervisory Authority (Finansinspektionen).

Vinge’s team consists of partner in charge Peter Sundgren (M&A), partner Emma Stuart-Beck (financial regulatory), partner Odile Fallenius and counsel Maria Schultzberg (tax) and associates Oscar Rydén and Louise Nordkvist (M&A).

Related

Vinge advises Calliditas Therapeutics in connection with Asahi Kasei Corporation’s public takeover offer

On 28 May 2024, Asahi Kasei Corporation announced a public takeover offer to the shareholders and holders of American Depositary Shares in Calliditas Therapeutics AB (publ) (”Calliditas Therapeutics”) to acquire all shares and American Depositary Shares (each representing two shares) in Calliditas Therapeutics.
May 28, 2024

Vinge has advised Alder on the establishment of Alder III

Vinge has advised Alder on the establishment of Alder's third and largest fund to date, Alder III.
May 27, 2024